Patrick M.J. Verhorst

A Randomized Controlled Trial in Second-Generation Zotarolimus-Eluting Resolute Stents Versus Everolimus-Eluting Xience V Stents in Real-World Patients

Clemens von Birgelen, Mounir W.Z. Basalus, Kenneth Tandjung et al. · Journal of the American College of Cardiology · 2012 · 248 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trial

Clemens von Birgelen, Hanim Sen, Ming Kai Lam et al. · The Lancet · 2013 · 198 citations

Medicine, Cardiology, Internal Medicine +15

Left atrial appendage flow velocity assessment using transesophageal echocardiography in nonrheumatic atrial fibrillation and systemic embolism

Patrick M.J. Verhorst, Otto Kamp, Cees A. Visser et al. · The American Journal of Cardiology · 1993 · 110 citations

Medicine, Cardiology, Internal Medicine +14

Long‐Term Outcome of Patients with Multiple (≥ 3) Noninfected Transvenous Leads: A Clinical and Echocardiographic Study

CAREL C. DE COCK, MAARTEN VINKERS, LINDA C.M.C. VAN CAMPE et al. · Pacing and Clinical Electrophysiology · 2000 · 103 citations

Medicine, Cardiology, Surgery +17

Tissue plasminogen activator activity and inhibition in acute myocardial infarction and angiographically normal coronary arteries

Freek W.A. Verheugt, Jan W. ten Cate, A. Sturk et al. · The American Journal of Cardiology · 1987 · 85 citations

Medicine, Cardiology, Pharmacology +14